<p>(A) Splenocytes and (B) MNCs were prepared from the spinal cord of both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10.PL mice immunized with MBP to induce EAE. The percentages of CD25<sup>+</sup>FoxP3<sup>+</sup> Treg cells among the total CD4<sup>+</sup> T cell population in splenocytes and MNCs were evaluated via flow cytometry (upper panel). Alternatively, splenocytes and MNCs were prepared from the spinal cord of both MBP TCR Tg B10.PL mice and β-actin-SRG3/MBP TCR double Tg B10.PL mice immunized with MBP to induce EAE. The percentages of CD25<sup>+</sup>FoxP3<sup>+</sup> Treg cells among the total CD4<sup>+</sup> T cell population in splenocytes and MNCs were evaluated via flow cytometry (lower panel). The mean values ± ...
<p>H/E technique show absence of blood infiltrates in control mice (A) while many infiltrates are ob...
<p>(A-B) Both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10.PL mice (upper panel) or bot...
<p>[A] The data are presented as percentage of Treg cells -CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>...
<p>Spinal cord-infiltrating cells isolated from EAE-induced mice, treated subsequently with ES-DCs (...
<p>(A) Splenocytes were prepared from both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10...
<p>(A-C) Both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10.PL mice (upper panel in Fig ...
<p><b>mice during EAE.</b> (<b>A</b>) The proportion of apoptotic (Annexin V<sup>+</sup>/Propidium i...
<p>MOG-immunized C57 mice received daily EPO or PBS treatment for 6 days (day 1–6). Spinal cords wer...
<p>(A) Splenocytes from CD150 or nontransgenic mice (control), inoculated i.n. with either MV or med...
(A) Representative image of spinal cords stained with TUNEL assay and T cell marker (CD3) at the pea...
<p>(A) Vehicle and SM934 treated mice were given daily i.p. injection of BrdU for 3 days from day 17...
<p>Inflammatory process in lumbar spinal cord sections stained with H&E in control (<b>A</b>), EAE (...
<p>(<b>A</b>) EAE was induced in mice of indicated genotype (n = 10) by immunization with MOGp35–55 ...
<p>Coronal spinal cord sections showed little infiltration of GFP-labeled bone marrow-derived cells ...
<p>On day 4 after the second treatment, the spinal cords were digested by collagenase D and DNaseI a...
<p>H/E technique show absence of blood infiltrates in control mice (A) while many infiltrates are ob...
<p>(A-B) Both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10.PL mice (upper panel) or bot...
<p>[A] The data are presented as percentage of Treg cells -CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>...
<p>Spinal cord-infiltrating cells isolated from EAE-induced mice, treated subsequently with ES-DCs (...
<p>(A) Splenocytes were prepared from both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10...
<p>(A-C) Both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10.PL mice (upper panel in Fig ...
<p><b>mice during EAE.</b> (<b>A</b>) The proportion of apoptotic (Annexin V<sup>+</sup>/Propidium i...
<p>MOG-immunized C57 mice received daily EPO or PBS treatment for 6 days (day 1–6). Spinal cords wer...
<p>(A) Splenocytes from CD150 or nontransgenic mice (control), inoculated i.n. with either MV or med...
(A) Representative image of spinal cords stained with TUNEL assay and T cell marker (CD3) at the pea...
<p>(A) Vehicle and SM934 treated mice were given daily i.p. injection of BrdU for 3 days from day 17...
<p>Inflammatory process in lumbar spinal cord sections stained with H&E in control (<b>A</b>), EAE (...
<p>(<b>A</b>) EAE was induced in mice of indicated genotype (n = 10) by immunization with MOGp35–55 ...
<p>Coronal spinal cord sections showed little infiltration of GFP-labeled bone marrow-derived cells ...
<p>On day 4 after the second treatment, the spinal cords were digested by collagenase D and DNaseI a...
<p>H/E technique show absence of blood infiltrates in control mice (A) while many infiltrates are ob...
<p>(A-B) Both MBP TCR Tg B10.PL mice and CD2-SRG3/MBP TCR double Tg B10.PL mice (upper panel) or bot...
<p>[A] The data are presented as percentage of Treg cells -CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>...